To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine

Exclusion Criteria

• •Tympanic temperature of 38℃ or above within 48 hours prior to the vaccination or on the day of vaccination
• •Moderate to severe acute or chronic infectious disease on the day of vaccination
• •History of sensitivity to the following drugs: neomycin, formaldehyde, gentamicin sulfate, any preventive vaccines
• •Disorders in the immune system, or congenital or acquired immunodeficient diseases
• •Received immunosuppressive dose of systemic corticosteroids therapy within 12weeks days before vaccination
• •A child with uncontrolled epilepsy or neurological disorders
• •Planned with other vaccine within 4 weeks after the vaccination date
• •Administered with other vaccine within 4 weeks prior to the vaccination date
• •Used immunoglobulin formulation or human plasma, or received a transfusion within 12 weeks prior to the vaccination date
• •A child who has participated or is participating in another clinical trial within 12 weeks prior to the vaccination date(systemic corticosteroids administered at doses corresponding to ≤0.5 mg/kg/day of prednisolone for 14 consecutive days or less is exceptionally allowed)
• •Other reasons not specified above that, in the opinion of the investigator, may make the subject ineligible to participate in the study